Ensign Peak Advisors
GRCL

Ensign Peak Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Ensign Peak Advisors’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$232K Hold
2022
Q3 		$324K Hold
2022
Q2 		$554K Hold
2022
Q1 		$235K Buy